key: cord-0077736-qh8i6x2v
authors: Zhu, Yuan; Peng, Zhiyong
title: Editorial - Focus on the Study of Coronavirus Disease 2019
date: 2020-10-28
journal: nan
DOI: 10.4103/jtccm.jtccm_17_20
sha: 751ac85fcf64683e7cb5b4c80c4d1d438e731958
doc_id: 77736
cord_uid: qh8i6x2v

nan

T he coronavirus disease 2019 (COVID-19), which is characterized by fast person-to-person transmission causedand by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has become a global pandemic changing people's lifestyle and even threatening people's life. As of August 29, COVID-19 has yielded more than 24 million confirmed cases and 827,730 deaths, according to the World Health Organization. [1] The European Centre for Disease Prevention and Control reported that about 80% of cases are asymptomatic or mild disease, 14% have severe disease, and 6% need intensive care. [2] Such a high proportion of asymptomatic and mild infections may partly explain the rapid spread of SARS-CoV-2. America, Europe, and South-East Asia are the main battlegrounds of this tough warfare between SARS-CoV-2 and not only the frontline health-care workers but also, we humans. The ongoing pandemic has changed the way of learning and working of every person on the planet, brought the exhaustion of health-care workers, and caused the strained supply chain of health-care resources. In a long run, the pandemic may even lead to the collapse of the global health-care system as well as the global economy if it is not effectively contained.

COVID-19 erupted so suddenly that we basically knew nothing about it at first. Scientists and health-care professionals worldwide are trying to know COVID-19 and SARS-CoV-2 better and they had made some breakthroughs: the clinical manifestations [3] and histopathological changes [4] in the infected lung tissue of COVID-19 had been summarized and the structure and genetical characterization, the host source, the interaction with angiotensin-converting enzyme 2 protein receptor, and the epidemiological characteristics of SARS-CoV-2 were also discovered. [5] However, more information about its biology, epidemiology, genetic variation, pathophysiology, and treatment is still waiting to be investigated. The international community has also noticed the long-term impact of this global pandemic on mental health, health disparities, education method, society functioning, economic development, and international relations. Some clinical trials on the efficacy of potentially effective treatments are in process, but few treatments have been proven strongly effective against COVID-19 based on completed clinical trials on this stage. So far, rapid diagnosis and vaccines may be the most promising means to curb this global pandemic. To contain the spread of disease and help care for those affected, the World Health Organization is attempting to bring global scientists together and build a COVID-19 database to accelerate the process of diagnosis, vaccines, and therapeutics.

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard 2020

COVID-19): Increased Transmission Globally-Fifth Update

COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge

A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression

SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions